Cefixime + Clavulanate Potassium Dry Syrup Manufacturer & Exporter

Product Overview
Key Features
Therapeutic Uses
Dosage Form Advantages

Genliva Wellness LLP develops Cefixime + Clavulanate Potassium Dry Syrup for pediatric bacterial infections requiring stronger antibacterial protection against resistant organisms. The formulation is widely administered in recurrent tonsillitis, sinusitis, otitis media, bronchial infections, and pediatric respiratory bacterial conditions.

Cefixime belongs to the third-generation cephalosporin antibiotic class and provides extended antibacterial coverage, while Clavulanate Potassium improves effectiveness by blocking beta-lactamase enzymes produced by resistant bacteria. As a trusted Pediatric Antibiotic Dry Syrup Exporter, Genliva Wellness LLP manufactures pediatric oral antibiotic formulations with smooth reconstitution and effective bacterial control.

Recognized as a Cefixime Clavulanate Dry Syrup Manufacturer in India, Genliva Wellness LLP supplies pediatric cephalosporin formulations to pharmaceutical distributors and international healthcare markets.

Cefixime + Clavulanate Potassium Dry Syrup is formulated for resistant pediatric bacterial infection treatment.

Third-generation cephalosporin and clavulanate combination
Effective against resistant respiratory bacteria
Smooth reconstitution for pediatric administration
Helps manage ENT and airway infections

This formulation is commonly used for pediatric resistant bacterial infection treatment.

Treatment of throat and sinus infections
Management of otitis media and bronchitis
Used in pediatric respiratory infection therapies
Helps control resistant bacterial growth
Improves recovery from recurrent infections

Cefixime + Clavulanate Potassium Dry Syrup provides advanced antibacterial coverage for pediatric infections.

Effective against beta-lactamase producing bacteria
Useful in recurrent ENT infection treatment
Improves antibacterial effectiveness in resistant infections
Provides convenient oral administration for children
Delivers dependable cephalosporin activity